Ian Marks’ Post

🔬 Breakthrough in Cancer Research 🔬 UC Irvine's team led by Remi Buisson has identified two key enzymes, APOBEC3A and APOBEC3B, as new targets for cancer treatment strategies. This landmark discovery highlights their role in cancer mutation, disease progression, and resistance to treatments. Dr. Buisson’s work was initially funded by the UCI Anti-Cancer Challenge in 2018. Support from the UCI Anti-Cancer Challenge propels essential research efforts like these, moving us closer to defeating cancer. Read more about how this research could transform cancer therapy at https://lnkd.in/gbkRC3aU. #cancerresearch #cancertreatment #supportcancerresearch

aacr24: moderna: mrna: potential : cancer: types: immuno oncology:

This is what #RewritingCancer looks like. Our next-generation antibody-drug conjugate (#ADC) technology is designed to deliver cancer-killing agents directly to tumours.   I'm proud to share this look 'behind the science' video, as Pfizer's Head of ADC Discovery and Cancer Immunology, Scott Peterson, shows how we are helping to change the trajectory of cancer treatment in the new BBC StoryWorks series.   Read more about how we are accelerating cancer breakthroughs here: https://lnkd.in/griFfuFJ #ADCs #CancerResearch #OutDoCancer

Immunotherapy has significantly improved cancer treatments by harnessing the body's immune system to target and destroy cancer cells. Yet, developing these groundbreaking therapies is complex, especially with the limitations of traditional cell models. 🎥 Watch our on-demand webinar to: - Gain insights from immuno-oncology researchers on the transition from traditional cell cultures to dynamic 3D cell models. - Understand the challenges of adopting organoid technology and discover strategies for successful implementation. - Learn about the advancements that 3D organoids are bringing to the field of immunotherapeutic cancer treatments. Watch now: https://ow.ly/pPKV50U4h1W #Immunotherapy #CancerResearch #3DCellModels #Organoids #Webinar

🔬The Power of the Microbiome in Cancer Therapy! Recent research reveals that **gut microbes** play a pivotal role in enhancing the effectiveness of cancer immunotherapy. However, it also emphasizes the risks posed by **antibiotic-induced dysbiosis**, which can significantly impact survival outcomes in cancer patients. This groundbreaking discovery highlights the need to consider microbiome health in personalized medicine and cancer treatment strategies. #CancerResearch #GutHealth #Immunotherapy #InnovationInScience"

A ray of hope in cancer research: A melanoma cancer vaccine with minimal side effects is nearing phase 3 trials. 💉🔬 ◾ This promising development could significantly advance melanoma treatment, offering new hope to patients worldwide. ◾ As we navigate the complex landscape of cancer research, each breakthrough brings us one step closer to a cure. 💡🌐 ◾ This could be a significant advancement and has great potential for cancer treatment. Medical advancement in cancer is exciting. We hope there may be more good news to come. #CancerResearch #MelanomaVaccine #MedicalBreakthrough Source: https://lnkd.in/ecG6tF4r

A ray of hope in cancer research: A melanoma cancer vaccine with minimal side effects is nearing phase 3 trials. 💉🔬 ◾ This promising development could significantly advance melanoma treatment, offering new hope to patients worldwide. ◾ As we navigate the complex landscape of cancer research, each breakthrough brings us one step closer to a cure. 💡🌐 ◾ This could be a significant advancement and has great potential for cancer treatment. Medical advancement in cancer is exciting. We hope there may be more good news to come. #CancerResearch #MelanomaVaccine #MedicalBreakthrough Source: https://lnkd.in/e9xhg_92

A ray of hope in cancer research: A melanoma cancer vaccine with minimal side effects is nearing phase 3 trials. 💉🔬 ◾ This promising development could significantly advance melanoma treatment, offering new hope to patients worldwide. ◾ As we navigate the complex landscape of cancer research, each breakthrough brings us one step closer to a cure. 💡🌐 ◾ This could be a significant advancement and has great potential for cancer treatment. Medical advancement in cancer is exciting. We hope there may be more good news to come. #CancerResearch #MelanomaVaccine #MedicalBreakthrough Source: https://lnkd.in/eSdxStbV

What are the highlights from our #AACR poster? Michael J. Newman, Ph.D., our Founder and Chief Scientific Officer, discusses how our innovative Decoy platform activates the immune system to recognize and combat cancer more effectively. Our recent mechanism of action study showed promising results in maturing and activating human immune cells to fight cancer directly. Stay tuned for more updates as we continue our mission to transform cancer therapy! $INDP #IndaptusTherapeutics #CancerResearch #Decoy20 #Immunotherapy 

News in Cancer Research! 🚨 A new proof-of-concept for a universal cancer vaccine is showing incredibly promising results! 🧬 This breakthrough works by training the immune system to recognize and target cancer cells, potentially leading to a broad-spectrum vaccine that could protect against various cancer types. Although still in its early stages, this research could revolutionize cancer treatment, moving us closer to a world where immunotherapy replaces more invasive options like chemotherapy or radiation. 🌍💉 Researchers are optimistic about future developments, and this could mark a turning point in the fight against cancer. #CancerResearch #Immunotherapy #MedicalInnovation #Healthcare #Bioimformatics